November 10, 2025
MSN highlighted research led by the University of Cincinnati Cancer Center's Trisha Wise-Draper showing a combination of immunotherapy medications can activate a robust immune response and help overcome treatment resistance in patients with refractory melanoma.
November 10, 2025
The University of Cincinnati’s Jiajie Diao, PhD, and colleagues have published new research showing a proof of concept that rearranging the location of lipid droplets within cells can increase the effectiveness of cell starvation, making it a potential cancer treatment. The research was published as the November cover story in the journal Trends in Biotechnology.
November 7, 2025
The University of Cincinnati Cancer Center’s Trisha Wise-Draper, MD, PhD, will present early data from a Phase 2 clinical trial showing a combination of immunotherapy medications can activate a robust immune response and help overcome treatment resistance in patients with refractory melanoma at the Society for Immunotherapy of Cancer 40th Anniversary Annual Meeting Nov. 7.
November 6, 2025
The Dayton Daily News spoke with the University of Cincinnati's Joseph Broderick to discuss a recent article he wrote examining the past, present and future of stroke care.
November 6, 2025
Researchers at the University of Cincinnati Cancer Center have recently published research examining how new protocols affect postoperative opioid use and the effects of smoking cessation before surgery and declining surgery on overall survival.
October 31, 2025
The University of Cincinnati Cancer Center's Thomas Herzog joined WVXU's Cincinnati Edition to discuss the importance of HPV vaccination and pap testing for the prevention and early detection of cervical cancer.
October 30, 2025
The University of Cincinnati Cancer Center's Carla Justiniano joined WVXU's Cincinnati Edition to discuss the rise in cancer diagnoses among younger people.
October 29, 2025
The University of Cincinnati is a site for the TRACK-TBI-APT clinical trial, testing three medications as potential new treatments for TBI.
October 28, 2025
Medscape highlighted new trial results led by the University of Cincinnati's Eva Mistry that found an experimental drug shows promise in protecting injured brain cells for patients with acute ischemic stroke.
October 27, 2025
The University of Cincinnati's Kelly Dobos was featured in a Women's Health article discussing squalane, an ingredient being increasingly used in moisturizing skincare products.